newsfilter
← Latest News
GlobeNewswire·

VERAXA Biotech AG Appoints Carl von Halem as Interim Chief Financial Officer and Successor to Torsten Bürgermeister

ZURICH, SWITZERLAND – July 10, 2026 -- VERAXA Biotech AG (NASDAQ:VRXA, "VERAXA")), an emerging leader in designing novel cancer therapies, today announced the appointment of Carl von Halem as Interim Chief